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Article Synopsis:  
This study employed focus groups to explore Healthy Living Champions’ (HLC) opinions on 
the networking opportunities available and their contribution to sustained participation in the 
Healthy Living Pharmacy initiative. 
The outcomes have added to the existing body of evidence that HLCs are motivated to 
develop their role in delivering pharmacy services and are key facilitators in the continued 
success of the HLP project.  
This research has identified the important contribution of HLC network meetings in providing 
HLCs with professional development, networking opportunities and continued enthusiasm.  
Furthermore this study offers recommendations to develop and sustain the HLC network. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
Background: HLP evaluations recognise HLCs as key contributors to the project’s success; 
the project has served to reduce pressure on family doctor services and clients who would 
have otherwise not sought professional advice have accessed HLP services.  
Objectives: To investigate the impact of innovative networking opportunities in supporting 
HLCs to function within their role and to explore the network’s potential in promoting 
sustained HLP participation. 
 
Method: Twenty of Portsmouth’s HLCs (n=33) agreed to participate in focus groups. 
Transcripts were subjected to interpretative phenomenological analysis guided by grounded 
theory. The transcripts were read repeatedly; recurrent themes were identified and coded 
manually and consensus was reached by discussion within the research team. 
Findings: Network meetings provide HLCs with professional development, networking 
opportunities and continued encouragement. Recommendations to develop and sustain the 
network included the formation of a group committee and establishing of a communication 
facility accessible between meetings. 
Conclusion: The successful Portsmouth HLP project informed the design of UK HLP 
projects. The current focus is to build a successful strategy to sustain the positive outcomes, 
building on the recognised enablers. This study contributes further lessons learnt to guide 
health commissioners and service implementers to best support staff development, 
involvement and motivation through innovative practice. 
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Introduction 
Within global health policy, self-care is becoming an increasingly prominent element of 
patient care1-3. Community pharmacy offers a number of benefits as a setting for delivering 
self-care activities and advice. With extended opening hours and no appointment needed for 
advice, community pharmacy can be more accessible than other settings4. Research has 
recognised that the public trusts advice received from community pharmacies5. A review of 
evidence has confirmed the potential of pharmacy in the area of delivering public health 
initiatives, and suggests that pharmacy teams can make a positive contribution to public 
health6.  
The White Paper, Pharmacy in England: Building on strengths, delivering the future (2008)7 
identified the potential for establishing a role for community pharmacies within the public 
health service sector across England. Recommendations were made to increase pharmacy’s 
contribution to promoting better health, prevention and early detection of disease and 
managing patients with long-term conditions. 
The Healthy Living Pharmacy (HLP) initiative is a Department of Health (DoH) 
commissioned project designed to quality-assure the delivery of health and well-being 
services that address local health inequalities8.   
The project, piloted in Portsmouth in 2010 and rolled out nationally in 2011, appears to have 
made a positive impact on community pharmacy services9. It has produced a strong 
community of participating pharmacies and clients have benefitted from the services 
provided10, 11. Table 1 illustrates key benefits to pharmacy contractors who adopted the HLP 
model.  
Table 1:UK HLP evaluation of pharmacy contractors (n=153)10 
 
33% experienced higher prescription volumes 
43% reported a rise in income  
61% experienced increased demand for services 
80% found staff were more productive 
 
The national evaluation also identified that 20% of individuals (n=1034) using HLP services 
would not have accessed services elsewhere, thus facing the risk of deterioration in their 
health, and 60% of individuals would have otherwise accessed their family doctor, thus 
further burdening this already overwhelmed resource12. The evaluation also recognised, in 
different demographics and geographies, there is a consistent performance across different 
services delivered by HLPs, suggesting that the HLP concept can be replicated in other 
areas.  
An extensive body of evidence demonstrates the improved health outcomes from community 
pharmacy initiatives6, 9. However, research has indicated that although the diversifying role of 
community pharmacy from traditional dispensing activities to greater involvement in health 
improvement is largely accepted, and the importance of providing health and well-being 
services is understood, the role is still considered secondary to medicine related roles. 
However despite some initial success, many pharmacists view public health activities as less 
important than traditional roles and cite lack of time and confidence as barriers to further 
expansion of service provision5, 6, 13.   
It has since been recognised that employing the appropriate skill mix in community 
pharmacy is a key enabler in enhancing pharmaceutical care by making better use of the 
knowledge and aptitude of pharmacy support staff and pharmacists14. Effective use of skill 
mix in upskilling support staff and education provision has resulted in improved efficiency, 
sustained service involvement and freeing up pharmacist’s time15.  
 
The HLP framework recognised the benefits of skill mix and considered the integral 
contribution pharmacy support staff could have in service delivery10, 11. To deliver the HLP 
concept there was a criterion for a non-pharmacist member of staff to undergo further 
training and become a Healthy Living Champion (HLC). The role of the HLC includes 
proactively engaging with the public, understanding the local health and well-being services 
available, establishing and maintaining a health promotion zone and delivering health and 
well-being services within the pharmacy. 
 
Table 2 summarises some of the training available for HLCs.  
 
Table 2: Training for HLCs 
There are many national and local organisations that provide accredited HLC courses 
including the core Royal Society for Public Health’s(RSPH) Understanding Health 
Improvement Level 2 qualification16 
This course consists of four modules followed by a Multiple Choice Question assessment:  
 Inequalities in health  
 How effective communication can support health messages 
 Importance of promoting improvements in health and well-being 
 Impact of behaviour change on health and well-being 
 
In addition the RSPH offers other qualifications to further develop the skills and knowledge of 
a Healthy Living Champion: 
 Level 2 Award in Applied Health Improvement 
 Level 2 Award in Encouraging a Healthy Weight and Healthy Eating 
 Level 2 Award in Encouraging Physical Activity 
 Level 2 Award in Health Promotion (General Health and Wellbeing) 
 Level 2 Award in Health Promotion (Oral Health) 
 Level 2 Award in Supporting Smoking Cessation 
 Level 2 Award in Understanding Alcohol Misuse 
 Level 2 Award in Understanding Behaviour Change 
 Level 2 Award in Understanding the Delivery of an NHS Health Check 
 
 
 
Research investigating HLP success revealed the key role HLCs played in motivating staff, 
networking and collaborating with local pharmacy teams in community outreach projects, 
and supporting continued engagement with the HLP project11. Furthermore, research has 
identified that pharmacy staff trained as HLCs embraced the role and saw personal and 
patient benefit in delivering pharmacy public health services17.  
 
In Portsmouth, a ‘pharmacy community’ was created11, whereby the HLCs formed a 
networking group and met periodically. HLCs reported that these meetings acted as a 
source of motivation to engage with HLP activities11. The local commissioner, therefore, 
continued to facilitate and fund networking meetings. The aim of this was to sustain the 
enthusiasm around HLP activities and to ensure the key role HLCs contribute in delivering 
HLP engagement, was supported with education and professional development.  
 
Although the key enablers for HLP delivery have been recognised in the literature10, 18, 19; 
research to identify the facilitators for continued participation has yet to be conducted.   
This study aimed to investigate the impact of innovative networking opportunities in 
supporting HLCs to function within their role and to explore the network’s potential in 
promoting sustained participation in the HLP initiative.  
 
Method 
All HLCs working in each of Portsmouth’s community pharmacies that were operating as 
HLPs (n=33) were invited to take part in focus groups held in a local community centre. Two 
focus groups, each of 10 volunteering participants were arranged to allow for optimal group 
size20. Care was taken in assigning individuals to each group to support heterogeneous 
grouping to avoid persons who work together being in the same group and the number of 
persons working for multiple-group pharmacies and independently owned pharmacies were 
equally divided.   
Prior to the focus group, questions were pre-tested and reviewed for face validity with 5 staff 
employed at a single community pharmacy, to ensure that the wording would be understood 
by all potential participants. The review determined that no changes to the wording of the 
questions were required.  
 
The focus group questions are outlined in Table 3.  
Table 3: Focus group questions 
 
Why do you attend the HLC meetings? 
Can you describe the impact brought about by attending these meetings? 
What are your thoughts on how the meetings are delivered?  
How can these meetings be improved?  
Are there aspects of the meetings you consider beneficial to your role? 
Is there anything you would like to see changed to the HLP meetings? 
What can be done to help sustain activity in the HLP project? 
 
The interview questions were designed to enable the participants to express their own 
opinions and experiences of the HLC meetings. To capture non-attenders and to consolidate 
the views expressed by those that did attend, a semi-structured questionnaire based on 
themes generated through the focus groups was circulated to all HLCs. 
Two trained assistants were present at each focus group: one as the moderator and the 
other managed audio-recording and making field notes20.  
The discussions were transcribed verbatim by the researcher (ZN) and checked by the 
trained assistants. Analysis was by way of interpretative phenomenological analysis guided 
by grounded theory21. The transcripts were read repeatedly; recurrent themes were identified 
and coded manually and consensus was reached by discussion between the researcher 
(ZN) and the two trained assistants. These were validated by a member of the research 
team (DB). 
This research received a favourable opinion from the Portsmouth NHS Local Research 
Ethics Committee as part of the wider evaluation of the HLP in Portsmouth.(ref 10/H05012/6) 
 
Results 
Twenty HLCs agreed to participate in the focus groups. Two focus groups, each of 10 
participants were arranged. Each focus group lasted approximately 40 minutes. The themes 
from the first focus group re-emerged from the second focus group with similar emphasis 
and frequency, achieving saturation. 
The semi-structured questionnaires confirmed the breadth of the themes and did not 
generate any further themes formulated in the focus groups. 
Table 4 identifies the themes and sub-themes that emerged from the 2 focus groups.  
Table 4: Themes and sub-themes to have emerged from the focus groups 
 
Theme        Sub-theme 
 
Benefits of attending 
the HLC meetings 
 An opportunity to network 
 A source of motivation to engage in HLP activities 
 A platform for discussions around health promotion 
campaigns 
 Sharing ideas of patient recruitment and service promotion 
 Initiating relationships for collaborative projects in the local 
community 
 A sense of community in working together to achieve 
similar goals 
Setup and content of 
the HLC meetings 
 A central location and convenient timing are important 
 A demonstration of good practice in delivering specific HLP 
services is a valued inclusion 
 Updates of specific pharmacies service activity and 
success acts to motivate further service delivery  
 Training delivered by practitioners involved in HLP services 
help contextualise the HLC role  
Future developments  An advanced schedule of HLC meetings  
 The formation of a group committee responsible for 
administrative tasks and communications 
 A facility to allow communications to continue in between 
meetings  
 
Discussion  
The HLP initiative demonstrates an effective platform through which community pharmacy’s 
role in delivering health and well-being services can be realised; this has been achieved 
through better utilisation of pharmacy staff15, 22, 23. Research has identified effective team 
working and staff motivation as key enablers and facilitators in supporting the HLP 
initiative11, 23. It would, therefore, seem unreasonable to consider implementation of the HLP 
project without considering the valuable role of HLCs and their contribution to sustained 
engagement in the project.  
Early suggestions of strategies to facilitate continued engagement of HLCs are beginning to 
appear in local HLP evaluation documents18, 19, 24; however, this report is the first to analyse 
the impact of such a strategy. Portsmouth, being the pilot site for the HLP project, was the 
first location to identify the potentially significant contribution of HLCs in HLP engagement.  
The investigation of the HLC community described in this study provides a valuable insight 
into their value for other HLP projects around the UK and further afield. It also helps to 
inform a business development model in the wider commercial environment. 
This study specifically identified the benefits for HLCs in attending networking meetings 
facilitated and funded by the local commissioner of the service. Firstly, HLCs were enthused 
and returned to their workplace feeling more motivated to continue in their role. Secondly, 
the meetings provided an opportunity for HLCs to share ideas and initiate collaboration for 
health promotional activities outside of the workplace. Thirdly, the training incorporated into 
the meetings enhanced the HLCs’ understanding of their role in public health services.  
These findings support published research demonstrating that HLPs lead to the creation of a 
‘pharmacy community’, whereby working relationships are established through interactions 
between staff at joint training sessions and continued communications in between 
sessions22. Furthermore, this study confirms research that has identified the role of the 
commissioner in supporting staff education and training to be important in HLP support22, 23. 
Similarly, it has been recognised in wider healthcare research, that communities working 
towards improving the health of specific groups of patients have found that they are more 
likely to be successful if they work collaboratively within their communities25. 
It should be recognised that when a public funding agency ceases to remain involved in 
community projects, the effectiveness of the collaboration within a network may be 
diminished26. The relevance of this is significant, since the commissioner’s role has been 
recognised to support the HLP initiative; however the dynamic nature of the National Health 
Service (NHS) commissioning environment means that continued involvement in the project 
is not guaranteed.  
The HLCs claimed that the absence of a facility for disseminating meeting details and 
allowing communication in between meetings resulted in variable HLC attendance. This was 
identified as a barrier impeding the progress and success of the meetings. HLCs saw the 
formation of a committee to take on the leadership of the group in managing 
communications and administrative functions to mitigate and improve poor communication 
previously encountered. 
Implementation of a communication tool, which serves the desired functions as mentioned 
by the HLCs and the formation of a group committee to undertake administrative functions 
are the next steps towards consolidating the sustainability of the HLP initiative through the 
motivation and contribution of HLCs.  
An evaluation of these enterprises, including qualitative feedback on the usability and 
perceived benefits of a communication tool; and also analysis on the impact on HLP delivery 
would then be necessary and provide valuable information for the future development and 
sustainability of HLP programs elsewhere.  
 
Conclusion 
The HLP project was introduced to improve patient outcomes by increasing pharmacy’s 
contribution to promoting better health, prevention and early detection of disease and 
managing patients with long-term conditions. Evaluations of the project throughout the UK 
are consistent in that the project produces a strong community of participating pharmacies 
and clients have benefitted from the services provided. Furthermore, there is evidence that 
the project has served to reduce pressure on family doctor services and HLP services have 
been accessed by patients who would have otherwise not sought professional advice.  
This study has added to the existing body of evidence that HLCs are motivated to develop 
their role in delivering pharmacy services and are key facilitators in continued participation in 
the HLP project. This research has identified the important contribution of HLC network 
meetings in providing HLCs with professional development, networking opportunities and 
continued enthusiasm.  
Furthermore this study offers recommendations to develop and sustain the HLC network, 
through the formation of a group committee and establishing a robust communication facility 
accessible in between meetings.  
The HLP project in Portsmouth is well established and the successful implementation has 
been employed to inform the design of HLP projects throughout the UK. The focus now is to 
build a successful strategy to sustain the positive outcomes building on the recognised 
enablers of the project. This study contributes further lessons learnt to guide health 
commissioners and service implementers to best support staff development, involvement 
and motivation through innovative practice. 
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